Literature DB >> 16740712

Identification of specific gene copy number changes in asbestos-related lung cancer.

Penny Nymark1, Harriet Wikman, Salla Ruosaari, Jaakko Hollmén, Esa Vanhala, Antti Karjalainen, Sisko Anttila, Sakari Knuutila.   

Abstract

Asbestos is a well-known lung cancer-causing mineral fiber. In vitro and in vivo experiments have shown that asbestos can cause chromosomal damage and aberrations. Lung tumors, in general, have several recurrently amplified and deleted chromosomal regions. To investigate whether a distinct chromosomal aberration profile could be detected in the lung tumors of heavily asbestos-exposed patients, we analyzed the copy number profiles of 14 lung tumors from highly asbestos-exposed patients and 14 matched tumors from nonexposed patients using classic comparative genomic hybridization (CGH). A specific profile could lead to identification of the underlying genes that may act as mediators of tumor formation and progression. In addition, array CGH analyses on cDNA microarrays (13,000 clones) were carried out on 20 of the same patients. Classic CGH showed, on average, more aberrations in asbestos-exposed than in nonexposed patients, and an altered region in chromosome 2 seemed to occur more frequently in the asbestos-exposed patients. Array CGH revealed aberrations in 18 regions that were significantly associated with either of the two groups. The most significant regions were 2p21-p16.3, 5q35.3, 9q33.3-q34.11, 9q34.13-q34.3, 11p15.5, 14q11.2, and 19p13.1-p13.3 (P < 0.005). Furthermore, 11 fragile sites coincided with the 18 asbestos-associated regions (P = 0.08), which may imply preferentially caused DNA damage at these sites. Our findings are the first evidence, indicating that asbestos exposure may produce a specific DNA damage profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740712     DOI: 10.1158/0008-5472.CAN-06-0199

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Deletion at fragile sites is a common and early event in Barrett's esophagus.

Authors:  Lisa A Lai; Rumen Kostadinov; Michael T Barrett; Daniel A Peiffer; Dimitry Pokholok; Robert Odze; Carissa A Sanchez; Carlo C Maley; Brian J Reid; Kevin L Gunderson; Peter S Rabinovitch
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

2.  Bayesian Frequentist hybrid Model wth Application to the Analysis of Gene Copy Number Changes.

Authors:  Ao Yuan; Guanjie Chen; Juan Xiong; Wenqing He; Charles Rotimi
Journal:  J Appl Stat       Date:  2011       Impact factor: 1.404

3.  Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.

Authors:  Alfred King-Yin Lam; Vinod Gopalan; Mohammad Reza Nassiri; Kais Kasim; Jayampathy Dissanayake; Johnny Chuek-On Tang; Robert Anthony Smith
Journal:  Mol Oncol       Date:  2011-07-12       Impact factor: 6.603

Review 4.  Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Authors:  Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 5.  Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Authors:  Brooke T Mossman; Morton Lippmann; Thomas W Hesterberg; Karl T Kelsey; Aaron Barchowsky; James C Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

6.  HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins.

Authors:  M K Singh; E Nicolas; W Gherraby; D Dadke; S Lessin; E A Golemis
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

7.  Genome-wide Gene-Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk.

Authors:  Chen-Yu Liu; Isabelle Stücker; Chu Chen; Gary Goodman; Michelle K McHugh; Anthony M D'Amelio; Carol J Etzel; Su Li; Xihong Lin; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-21       Impact factor: 4.254

8.  Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients.

Authors:  Penny Nymark; Mervi Aavikko; Jussi Mäkilä; Salla Ruosaari; Tuija Hienonen-Kempas; Harriet Wikman; Kaisa Salmenkivi; Risto Pirinen; Antti Karjalainen; Esa Vanhala; Eeva Kuosma; Sisko Anttila; Eeva Kettunen
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

9.  CGHpower: exploring sample size calculations for chromosomal copy number experiments.

Authors:  Ilari Scheinin; José A Ferreira; Sakari Knuutila; Gerrit A Meijer; Mark A van de Wiel; Bauke Ylstra
Journal:  BMC Bioinformatics       Date:  2010-06-17       Impact factor: 3.169

10.  DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure.

Authors:  E Kettunen; M Aavikko; P Nymark; S Ruosaari; H Wikman; E Vanhala; K Salmenkivi; R Pirinen; A Karjalainen; E Kuosma; S Anttila
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.